National's Plan to Cut Overseas Aid to Fund Pharmac Explained

National would cut New Zealand's foreign aid by $431 million and redirect the money to new medicines if it leads the next government.

The savings would come from Official Development Assistance, the official term for government aid, outside the Pacific. Aid to the Pacific would be protected. Funding in other regions, and the administration costs linked to it, would be reduced RNZ.

In detail, National would cut development aid by $431.2 million over four years. The party says that equals a 10% cut to foreign aid and related administration costs. It promises to lift the budget for Pharmac, the agency that buys subsidised medicines, by $604 million over the same period The Press. The party says the aid savings would also fund cancer screening as well as the medicines budget, and that it would cut funding to the Ministry of Foreign Affairs and Trade 1News. Simeon Brown is the party's health spokesperson.

Leader Christopher Luxon said the party believes "we should put our country and our people first". He cited workshops for Indigenous farmers in Patagonia as an example of aid that would be cut.

The baseline is an aid budget of about $1.2 billion in the 2025/2026 financial year. Nearly 60 percent of Official Development Assistance goes to the Pacific.

Massey University associate professor Gerard Prinsen warned the cut could make New Zealand "invisible" on the world stage. He said New Zealand now contributes to more than 40 UN bodies. He said aid to Africa is less than 1 percent of the aid budget.

The proposal has split the parties National would likely need under MMP, the voting system where parties often must join together to govern. NZ First leader Winston Peters called the promise "desperate". The ACT Party welcomed it as a win and promised to go further RNZ.

The broader context here is the maths facing any incoming finance minister. The Pacific takes most of the aid vote. Protecting it means the full $431 million must come from a much smaller pool of direct country aid, UN and multilateral payments and emergency relief. That concentrates the effect on UN contributions, aid outside the Pacific and staff capacity at the ministry.

Looking at what this means for the campaign, the trade is deliberate. Pharmac and cancer screening are local, concrete and easy to cost in a leaders' debate. Aid is distant for most voters, paid through multi-year budgets, and its diplomatic benefit is hard to measure. For policy staff, the questions to watch are which UN commitments would end, how the ministry would manage with less, and whether ACT and NZ First use the pledge as a starting point for coalition talks.